Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. Omega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly
India’s health care sector has long been seen as a sleeping giant. Over the last decade, it has begun to stir — and now, in many ways, it is fully awake. Between 2022 and 2025, the sector attracted over $20 billion in cumulative investments across private equity, venture capital, and mergers. Hospitals, diagnostics, biotechnology, insurance,
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. A private equity firm has stepped in to finance a biological research lab at Harvard
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got more news out of DC today – let’s get into it. Investors unfazed by FDA’s Covid vaccine framework The FDA announced yesterday that it will limit access to Covid-19 vaccines